Bacillus Coagulans

-Delile

• Kungenzeka kusebenze ...
• Ubufakazi obanele bokukala ukusebenza kwe ...
• Ukuqapha okukhethekile nezixwayiso:

I-Bacillus coagulans uhlobo lwama-bacteria. Isetshenziswa ngokufanayo ne-lactobacillus namanye ama-probiotic njengamagciwane "alusizo".

Abantu bathatha ama-Bacillus coagulans e-irritable bowel syndrome (IBS), isifo sohudo, igesi, ukutheleleka komoya, nezinye izimo eziningi, kepha abukho ubufakazi obuhle besayensi bokusekela lokhu kusetshenziswa.

I-Bacillus coagulans ikhiqiza i-lactic acid futhi ivame ukuhlukaniswa njenge-lactobacillus. Eqinisweni, eminye imikhiqizo yezentengiselwano equkethe iBacillus coagulans idayiswa njengeLactobacillus sporogenes. Ngokungafani namagciwane e-lactic acid afana ne-lactobacillus noma i-bifidobacteria, iBacillus coagulans yakha izinhlamvu. Izinhlamvu ziyinto ebalulekile ekutsheleni amaBacillus coagulans ngaphandle kwamanye amagciwane e-lactic acid.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze AmaBacillus COAGULANS zimi kanje:

Kungenzeka kusebenze ...

• Ukuphazamiseka kwesikhathi eside kwamathumbu amakhulu okubangela ubuhlungu besisu (i-irritable bowel syndrome noma i-IBS). Ucwaningo lomtholampilo lukhombisa ukuthi ukuthatha ama-Bacillus coagulans nsuku zonke izinsuku ezingama-56-90 kuthuthukisa izinga lempilo futhi kwehlise ukuqunjelwa, ukuhlanza, ubuhlungu besisu, kanye nenani lokuhamba kwamathumbu kubantu abane-IBS ebaluleke kakhulu. Olunye ucwaningo lomtholampilo lukhombisa ukuthi ukuthatha umkhiqizo othile wokuhlanganiswa (i-Colinox, i-DMG Italia SRL) equkethe ama-Bacillus coagulans kanye ne-simethicone kathathu nsuku zonke amasonto ama-4 kuthuthukisa ukuqunjelwa nokungakhululeki kubantu abane-IBS.

Ubufakazi obanele bokukala ukusebenza kwe ...

• Ukulimala kwesibindi (i-cirrhosis). Abantu abane-cirrhosis yesibindi banamathuba amaningi okuthuthukisa ukutheleleka okubizwa nge-bacterial peritonitis, noma i-SBP. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha inhlanganisela yama-probiotic aqukethe i-Bacillus coagulans namanye ama-bacterium kathathu nsuku zonke, kanye nomuthi i-norfloxacin, akubunciphisi ubungozi bomuntu bokuthola i-SBP.
• Ukuqunjelwa. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha iBacillus coagulans kabili nsuku zonke amaviki ama-4 kungathuthukisa ubuhlungu besisu nokungakhululeki kubantu abavame ukuqunjelwa.
• Uhudo. Ucwaningo lokuqala ezinsaneni olunezinyanga eziwu-6-24 ezinesifo sohudo lukhombisa ukuthi ukuthatha amaBacillus coagulans izinsuku ezifika kwezinhlanu akusinciphisi isifo sohudo. Kepha ukuthatha iBacillus coagulans kubonakala kuthuthukisa isifo sohudo nobuhlungu besisu kubantu abadala.
• Uhudo olubangelwa yi-rotavirus. Ukucwaninga kwasekuqaleni ezinganeni ezisanda kuzalwa kukhombisa ukuthi ukuthatha ama-Bacillus coagulans nsuku zonke unyaka owodwa kunciphisa ingozi yengane yokuthola isifo sohudo i-rotavirus.
• Igesi (ukuqumba). Ubufakazi bokuqala kubantu abanegesi ngemuva kokudla kukhombisa ukuthi ukuthatha isengezo senhlanganisela ethile equkethe ama-Bacillus coagulans kanye nenhlanganisela yama-enzyme nsuku zonke amasonto ama-4 akukuthuthukisi ukuqunjelwa noma igesi.
• Ukuqunjelwa (i-dyspepsia). Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha ama-Bacillus coagulans nsuku zonke amasonto ayi-8 kunganciphisa izimpawu zokubhodla, ukubhinca, nokunambitheka okumuncu. Olunye ucwaningo lukhombisa ukuthi ukuthatha ama-Bacillus coagulans kabili nsuku zonke amaviki ama-4 kunciphisa ubuhlungu besisu nokuqunjelwa.
• Ukukhula ngokweqile kwamagciwane emathunjini amancane. Ubufakazi bokuqala bukhombisa ukuthi ukusebenzisa umkhiqizo othile wama-probiotic (i-Lactol, i-Bioplus Life Sciences Pvt. Ltd.) equkethe ama-Bacillus coagulans nama-fructo-oligosaccharides nsuku zonke izinsuku eziyi-15 zenyanga ngayinye izinyanga eziyisithupha kunganciphisa ngesizotha ubuhlungu besisu negesi kubantu abanegciwane elingaba yingozi. emathunjini.
• Isifo samathambo (RA). Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha ama-Bacillus coagulans nsuku zonke izinsuku ezingama-60 ukwengeza ekwelashweni okujwayelekile kunganciphisa ubuhlungu, kepha akulinciphisi inani lamalunga abuhlungu noma avuvukele kubantu abane-RA. Ama-Bacillus coagulans nawo awathuthukisi ikhono lokwenza imisebenzi yokuphila kwansuku zonke kubantu abane-RA.
• Isifo esibi samathumbu ezinganeni ezingakazalwa ngaphambi kwesikhathi (necrotizing enterocolitis noma i-NEC). Izingane ezizalwa kusenesikhathi noma ezinesisindo esiphansi zisengozini enkulu yokuthola ukutheleleka okungathi sína emathunjini okuthiwa i-necrotizing enterocolitis. Ucwaningo lwangaphambilini kulezi zingane lukhombisa ukuthi ukuthatha ama-Bacillus coagulans nsuku zonke kuze kube uyaphuma esibhedlela akuvimbeli i-necrotizing enterocolitis noma ukufa. Kodwa-ke, ukuthatha i-Bacillus coagulans kukhulisa inani lezinsana ezikwaziyo ukubekezelela ukudla.
• Yakha amafutha esibindini kubantu abaphuza utshwala obuncane noma abangaphuzi (isifo sesibindi esinamafutha noma i-NAFLD).
• Ukuvimbela umdlavuza.
• Ukutheleleka komgudu wamathumbu ngamagciwane abizwa ngeClostridium difficile.
• Izinkinga zokugaya.
• Ukutheleleka kokugaya ukudla okungaholela ezilondeni (Helicobacter pylori noma H. ​​pylori).
• Ukuqinisa amasosha omzimba.
• Ukuvuvukala kwesikhathi eside (ukuvuvukala) emkhakheni wokugaya ukudla (isifo sokuvuvukala kwamathumbu noma i-IBD).
• Ukutheleleka kwemigwaqo yomoya.
• Ezinye izimo.

Kudingeka ubufakazi obuningi ukukala ama-Bacillus coagulans alokhu kusetshenziswa. Akukho lwazi olwanele lokwazi ukuthi ama-Bacillus coagulans angasebenza kanjani ngezinjongo zokwelashwa. Olunye ucwaningo lukhombisa ukuthi iBacillus coagulans ingakhuphula ukusebenza kwamasosha omzimba futhi yehlise amagciwane ayingozi.

Lapho ithathwa ngomlomo: Bacillus coagulans kuyinto OKUNGENZEKA UKUPHEPHA lapho kuthathwa ngomlomo. Ucwaningo lukhombisa ukuthi ama-Bacillus coagulans ngemithamo yamayunithi angama-2 billion colony ukwakha amayunithi (ama-CFU) nsuku zonke angasetshenziswa ngokuphepha izinyanga ezi-3. Ukweqiwa okuphansi kwama-Bacillus coagulans aze afike kuma-CFU ayizigidi eziyi-100 nsuku zonke angasetshenziswa ngokuphepha kuze kube unyaka owodwa.

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa nokuncelisa ibele: Alukho ulwazi olwanele olwanele mayelana nokuphepha kokuthatha ama-Bacillus coagulans uma ukhulelwe noma uncelisa ibele. Hlala ohlangothini oluphephile futhi ugweme ukusetshenziswa.

Izingane: Bacillus coagulans kuyinto OKUNGENZEKA UKUPHEPHA lapho ithathwa ngomlomo ezinganeni nasezinganeni. Olunye ucwaningo lukhombisile ukuthi amaBacillus coagulans afinyelela kwizigidi eziyi-100 zamakholoni akha amayunithi (ama-CFU) nsuku zonke angasetshenziswa ngokuphepha yizinsana kuze kube unyaka owodwa.

Maphakathi

Qaphela ngale nhlanganisela.

Imithi elwa namagciwane

Ama-antibiotic asetshenziselwa ukunciphisa amabhaktheriya ayingozi emzimbeni. Ama-antibiotic anganciphisa namanye amabhaktheriya emzimbeni. Ukuthatha ama-antibiotic kanye nama-Bacillus coagulans kunganciphisa izinzuzo ezingaba khona ze-Bacillus coagulans. Ukugwema lokhu kuhlangana okungenzeka, thatha iBacillus coagulans imikhiqizo okungenani amahora ama-2 ngaphambi noma ngemuva kwama-antibiotic.

Imithi eyehlisa amasosha omzimba (ama-Immunosuppressants)

Ama-Bacillus coagulans angakhuphula umsebenzi wamasosha omzimba. Ukuthatha ama-Bacillus coagulans kanye nemithi eyehlisa ukusebenza kwamasosha omzimba kunganciphisa ukusebenza kwale mithi.
Eminye imithi eyehlisa ukusebenza kwamasosha omzimba ifaka i-azathioprine (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (FK506, FK506 Prograf), sirolimus (Rapamune), prednisone (Deltasone, Orasone), corticosteroids (glucocorticoids), nabanye.

Akukho ukuxhumana okwaziwayo ngamakhambi nezengezo.

Akukho ukuxhumana okwaziwayo nokudla.

Imithamo elandelayo ifundwe ocwaningweni lwesayensi:

ABADALA

NGOMLOMO:

• Ngokuphazamiseka kwesikhathi eside kwamathumbu amakhulu okubangela ubuhlungu besisu (i-irritable bowel syndrome noma i-IBS): Bacillus coagulans (Lactospore, Sabinsa Corporation) 2 billion colony forming units (CFUs) nsuku zonke izinsuku ezingama-90. Bacillus coagulans (GanedenBC30, Ganeden Biotech Inc.) izigidi ezingama-300 kuya ezigidini ezi-2 ze-CFU nsuku zonke amasonto ayi-8. Futhi, umkhiqizo ohlanganisiwe othile (iColinox, i-DMG Italia SRL) oqukethe ama-Bacillus coagulans ne-simethicone usetshenzisiwe ngemuva kokudla ngakunye kathathu nsuku zonke amasonto ama-4.

B. Coagulans, Bacillus Bacteria, Bacillus Probiotics, Bactéries Bacilles, Bactéries à Gram Positif Sporogènes, Bactérie Gram Positive en Forme de Bâtonnet, i-Gram Positive Spore-Forming Rod, L. Sporogenes, Lactobacillus Sporogenes, Lactobacillus Sporogorenes, Ukwakha iLactobacillus.

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.

1. UKumar VV, uSudha KM, uBennur S, uDhanasekar KR. I-Bacillus coagulans i-GBI-30,6086 ene-enzyme yokugaya ukudla ekuthuthukiseni ukungagayeki kwenani labantu abasebenza ngokugula. J Ukunakekelwa Okuphambili Komndeni. 2020; 9: 1108-1112. Buka okungaqondakali.
2. UChang CW, Chen MJ, Shih SC, et al. I-Bacillus coagulans (PROBACI) ekwelapheni ukuqunjelwa okusebenza kakhulu kwamathumbu. Imithi (iBaltimore). 2020; 99: e20098. Buka okungaqondakali.
3. USoman RJ, Swamy MV. Ucwaningo olulindelekile, olungahleliwe, oluyimpumputhe kabili, olulawulwa nge-placebo, lokuhlola ukusebenza ngempumelelo nokuphepha kwe-SNZ TriBac, inhlanganisela yama-Bacillus probiotic enezinhlobo ezintathu zokungaphatheki kahle kwamathumbu okungatholakali. I-Int J Colorectal Dis. 2019; 34: 1971-1978. Buka okungaqondakali.
4. U-Abhari K, Saadati S, Yari Z, et al. Imiphumela ye-Bacillus coagulans supplementation ezigulini ezinesifo sesibindi esinamafutha esingewona utshwala: Isivivinyo somtholampilo esilawulwa ngokungahleliwe, esilawulwa yi-placebo. Umtholampilo Wezempilo ESPEN. 2020; 39: 53-60. Buka okungaqondakali.
5. UMaity C, uGupta AK. Ucwaningo lomtholampilo olulindelekile, olungenelela, olungenamkhawulo, oluyimpumputhe, olulawulwa nge-placebo ukuhlola ukusebenza nokuphepha kwama-Bacillus coagulans LBSC ekwelapheni isifo sohudo olunzima nokungaphatheki kahle esiswini. I-Eur J Clin Pharmacol. 2019; 75: 21-31. Buka okungaqondakali.
6. I-Hun L. Bacillus coagulans ithuthukise kakhulu ubuhlungu besisu nokuqunjelwa kweziguli ezine-IBS. I-Postgrad Med 2009; 121: 119-24. Buka okungaqondakali.
7. U-Yang OO, uKelesidis T, uCordova R, uKhanlou H.Ukuqedwa kwama-antiretroviral-suppressed-HIV-1 ukutheleleka okungalapheki ohlolweni olulawulwa yi-placebo olulawulwa kabili olungaboni. I-AIDS Res Hum Retroviruses 2014; 30: 988-95. Buka okungaqondakali.
8. UDutta P, uMitra U, uDutta S, et al. Isivivinyo somtholampilo esilawulwa ngokungahleliwe seLactobacillus sporogenes (Bacillus coagulans), esisetshenziswa njenge-probiotic ekwenzeni imitholampilo, kuhudo olunamanzi olunamandla ezinganeni. ITrop Med Int Health 2011; 16: 555-61. Buka okungaqondakali.
9. U-Endres JR, uClewell A, uJade KA, et al. Ukuhlolwa kokuphepha kokulungiswa kokuphathelene kwe-probiotic yenoveli, iBacillus coagulans, njengesithako sokudla. Ukudla Chem Toxicol 2009; 47: 1231-8. Buka okungaqondakali.
10. UKalman DS, uSchwartz HI, u-Alvarez P, et al. Isilingo sesiza esikabili esingahle senziwe, esingahleliwe, esimpumputhe kabili, esilawulwa nge-placebo sokuhlola imiphumela yomkhiqizo osuselwa kuBacillus coagulans kuzimpawu ezisebenzayo zegesi emathunjini. I-BMC Gastroenterol 2009; 9: 85. Buka okungaqondakali.
11. I-Dolin BJ. Imiphumela yokulungiselela i-Bacillus coagulans ephathelene nezimpawu zesifo sohudo-isifo esibuhlungu kakhulu samathumbu. Izindlela Zokuthola I-Exp Clin Pharmacol 2009; 31: 655-9. Buka okungaqondakali.
12. UMandel DR, u-Eichas K, uHolmes J. Bacillus coagulans: ukwelashwa okusebenzayo kokuqeda izimpawu zesifo samathambo ngokusho kwesilingo esingahleliwe, esilawulwayo. I-BMC Complement Altern Med 2010; 10: 1. Buka okungaqondakali.
13. USari FN, uDizdar EA, u-Oguz S, et al. Ama-probiotic omlomo: I-Lactobacillus sporogenes yokuvimbela i-necrotizing enterocolitis ezinganeni ezinesisindo esiphansi kakhulu: isilingo esingahleliwe, esilawulwayo. I-Eur J Clin Nutrit 2011; 65: 434-9. Buka okungaqondakali.
14. URiazi S, uWirawan RE, uBadmaev V, uChikindas ML. Ukuchazwa kwe-lactosporin, iphrotheni yenoveli elwa namagciwane ekhiqizwa yi-Bacillus coagulans ATCC 7050. J Appl Microbiol 2009; 106: 1370-7. Buka okungaqondakali.
15. UPande C, Kumar A, uSarin SK. Ukwengezwa kwama-probiotic ku-norfloxacin akuthuthukisi ukusebenza kahle ekuvikeleni i-peritonitis ebangelwa yi-bacterial peritonitis: isilingo esilawulwa ngokulawulwa okungahleliwe esilawulwa nge-placebo kabili. I-Eur J Gastroenterol Hepatol 2012; 24: 831-9. Buka okungaqondakali.
16. UMajeed M, Nagabhushanam K, Natarajan S, et al. I-Bacillus coagulans MTCC 5856 ukwengeza ekuphathweni kwesifo sohudo okuyisifo samathumbu esibuhlungu kakhulu: isifundo semitholampilo esilawulwa nge-placebo esilawulwa kabili. Umsoco J 2016; 15: 21. Buka okungaqondakali.
17. I-Chandra RK. Umphumela weLactobacillus ekwenzekeni nasekukhuleni kwesifo sohudo esibucayi ezinganeni. Isifundo esingaqondakali esilawulwa nge-placebo esiphindwe kabili I-Nut Res Res 2002; 22: 65-9.
18. UDe Vecchi E, Drago L.Lactobacillus sporogenes noma iBacillus coagulans: ukungazazi kahle noma ukubeka kabi amagama? I-Int J Probiotic Prebiotic 2006; 1: 3-10.
19. UJurenka JS. Ama-Bacillus coagulans: I-Monograph. I-Altern Med Rev 2012; 17: 76-81. Buka okungaqondakali.
20. Urgesi R, uCasale C, uPistelli R, et al. Isivivinyo esilawulwa ngokungahleliwe se-placebo esilawulwa ngokungahleliwe ekusebenzeni nasekuphepheni kwenhlangano ye-simethicone neBacillus coagulans (Colinox) ezigulini ezine-irritable bowel syndrome. I-Eur Rev Med Pharmacol Sci 2014; 18: 1344-53. Buka okungaqondakali.
21. UKhalighi AR, Khalighi MR, Behdani R, et al. Ukuhlola ukusebenza ngempumelelo kwama-probiotic ekwelashweni kweziguli ezine-bacterial overgrowth encane (SIBO) - isifundo somshayeli. I-Indian J Med Res. Unyaka ka-2014; 140: 604-8. Buka okungaqondakali.
22. UCzaczyk K, Tojanowska K, Mueller A. Umsebenzi we-Antifungal we-Bacillus coagulans ngokumelene neFusarium sp. I-Acta Microbiol Pol 2002; 51: 275-83. Buka okungaqondakali.
23. UDonskey CJ, uHoyen CK, uDas SM, et al. Umphumela wokuphathwa kwe-Bacillus coagulans ngomlomo kokuminyana kwe-enterococci emelana ne-vancomycin esitokisini samamagundane akoloni. ILett Appl Microbiol 2001; 33: 84-8. Buka okungaqondakali.
24. IHyronimus B, Le Marrec C, i-Urdaci MC. I-Coagulin, i-bacteriocin-like inhibitory subtances ekhiqizwa yi-Bacillus coagulans I4. UJ Appl Microbiol 1998; 85: 42-50. Buka okungaqondakali.
25. Ama-Probiotic ohudo oluhambisana namagciwane. Incwadi ka-Pharmacist's Letter / Prescriber's 2000; 16: 160103.
26. UDuc LH, Hong HA, uBarbosa TM, et al. Ukuchazwa kwama-probiotic we-Bacillus atholakalayo ukuze asetshenziswe ngabantu. I-Appl Environ Microbiol 2004; 70: 2161-71. Buka okungaqondakali.
27. IVelraeds MM, van der Mei HC, Reid G, Busscher HJ. Ukuvinjelwa kokunamathela kokuqala kwe-uropathogenic Enterococcus faecalis ngama-biosurfactants aqhamuka eLactobacillus. I-Appl Environ Microbiol 1996; 62: 1958-63. Buka okungaqondakali.
28. UMcGroarty JA. Ukusetshenziswa kwe-Probiotic ye-lactobacilli epheshaneni lomuntu wesifazane urogenital. I-FEMS Immunol Med Microbiol 1993; 6: 251-64. Buka okungaqondakali.
29. Reid G, Bruce AW, Cook RL, et al. Umphumela kwizimbali ze-urogenital zemithi elwa namagciwane yokutheleleka nge-urinary tract I-Scand J Infect Dis 1990; 22: 43-7. Buka okungaqondakali.

Kugcine ukubuyekezwa - 12/04/2020